Go

Breaking News on Pharmaceutical Technology

All feeds

News headlines > Materials & Formulation

Text size Print Email this page

Novartis osteoporosis drug gets EU nod

By Katrina Megget, 08-Oct-2007

Related topics: Materials & Formulation, Ingredients, excipients and raw materials

Swiss pharma Novartis has got the thumbs up from the EU for its once-yearly treatment for postmenopausal osteoporosis.

Related Products, Brochures, Web links

Product presentations